Nanobiotix Newswire

Comprehensive Real-Time News Feed for Nanobiotix.

Results 1 - 20 of 38 in Nanobiotix

  1. French Cancer Treatment Developer To Expand To U.S. With Boston OfficeRead the original story

    Tuesday Sep 23 | Banker & Tradesman

    Laurent Lvy, CEO of Nanobiotix, and Gov. Deval Patrick officially announced the opening of the company's U.S. affiliate during a ceremony on Sept. 19 at the U.S. embassy in Paris in the company of Susan Windham-Bannister, CEO and President of the Massachusetts Life Sciences Center.

    Comment?

  2. French biotech Nanobiotix to open 1st U.S. office in BostonRead the original story w/Photo

    Tuesday Sep 23 | Business Journal

    Nanobiotix, a France-based developer of potential therapies to treat cancer, said it intends to open its first U.S. office in Boston.

    Comment?

  3. Nanobiotix Expands Operations Into The U.S.A. As Part Of Its International Development StrategyRead the original story

    Monday Sep 22 | BioSpace

    Affiliate opened in the Massachusetts Life Sciences Center A senior pharmaceutical executive appointed as Vice President Corporate Development Paris, France, September 22, 2014 - NANOBIOTIX , a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces today the opening of its first US office in Boston, Massachusetts, the global center for life sciences.

    Comment?

  4. Nanobiotix Expands Operations into the USA as Part of Its International Development StrategyRead the original story

    Monday Sep 22 | Freshnews

    NANOBIOTIX , a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces today the opening of its first US office in Boston, Massachusetts, the global center for life sciences. Laurent Levy, CEO of Nanobiotix, and Deval Patrick, Governor of Massachusetts state, officially announced the opening of the company's US affiliate during a ceremony on Friday September 19, 2014 at the US embassy in Paris, France, in the presence of Dr Susan Windham-Bannister, CEO and President of the Massachusetts Life Sciences Center.

    Comment?

  5. Gov. Patrick returning from European trade missionRead the original story w/Photo

    Saturday Sep 20 | KRNV-TV Reno

    Patrick said the trip was intended to expand opportunities between Massachusetts and European countries in the innovation economy, clean tech, digital gambling, financial services and education sectors. On Friday Patrick announced that Nanobiotix - a Paris-based nano-medicine company pioneering new approaches for cancer treatment - will open its first U.S. office in Massachusetts.

    Comment?

  6. Massachusetts Governor Deval PatrickRead the original story w/Photo

    Saturday Sep 20 | KVBC-TV Las Vegas

    Patrick said the trip was intended to expand opportunities between Massachusetts and European countries in the innovation economy, clean tech, digital gambling, financial services and education sectors. On Friday Patrick announced that Nanobiotix - a Paris-based nano-medicine company pioneering new approaches for cancer treatment - will open its first U.S. office in Massachusetts.

    Comment?

  7. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Monday Sep 8 | Business Wire

    ... is excited to announce the launch of Voices in Life Sciences (VLS) at the 2014 D... )--Regulatory News : Nanobiotix (Paris:NANO) : Place de cotation : Euronext Paris Compartiment : Compartiment C Code ISIN : FR0011341205 Site web : ...

    Comment?

  8. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Monday Sep 8 | Business Wire

    ... is excited to announce the launch of Voices in Life Sciences (VLS) at the 2014 D... )--Regulatory News : Nanobiotix (Paris:NANO) : Place de cotation : Euronext Paris Compartiment : Compartiment C Code ISIN : FR0011341205 Site web : ...

    Comment?

  9. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Aug 28, 2014 | Business Wire

    A ... )--The U.S. India Business Council led a delegation of medical device executives from Abbott, Baxter, Boston Scientific, Covidien, GE Healthcare, Johnson & John... )--Regulatory News : NANOBIOTIX , sociA tA franA aise pionniA re en nanomA decine dA veloppant NanoXray, une approche thA rapeutiqu... )--Regulatory ... (more)

    Comment?

  10. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Aug 28, 2014 | Business Wire

    ... from Abbott, Baxter, Boston Scientific, Covidien, GE Healthcare, Johnson & John... )--Regulatory News : NANOBIOTIX (Paris:NANO) (Euronext : NANO - ISIN: FR0011341205), sociA tA franA aise pionniA re en nanomA decine dA veloppant ...

    Comment?

  11. Recent Study: Brain Tumor - Pipeline Review, H2 2014Read the original story

    Jul 21, 2014 | SBWire

    ... from pipeline Companies Mentioned in this Report: Chong Kun Dang Pharmaceutical Corp., Pfizer Inc., Bayer AG, Nanobiotix, Hutchison MediPharma Limited, Siena Biotech S.p.A., Oncovir, Inc., DEKK-TEC, Inc., SignPath Pharma Inc, CalAsia ...

    Comment?

  12. Small Cap Share Tips: Nanobiotix secures funding to fight cancerRead the original story w/Photo

    Jul 14, 2014 | Daily Mail

    ... star performing technology stocks. The year to date has been one of incredible progress for Euronext-listed Nanobiotix with the advances reflected in a share price that has appreciated 200 per cent in that short time. The group, whose technology ...

    Comment?

  13. Small Cap Movers: Proteome Sciences shares' receive welcome boost...Read the original story w/Photo

    Jul 11, 2014 | Daily Mail

    ... for making arthritis treatment Humira, is stalking Dublin-based Shire with a view to pulling off a tax inversion Nanobiotix, which is developing a significant advance on traditional radiotherapy, told investors revenues for the quarter were a 48,596 ...

    Comment?

  14. Nanobiotix Revenue For The 2nd Quarter Of 2014Read the original story

    Jul 11, 2014 | BioSpace

    In EUR Q2 2014 H1 2014 Q2 2013 ----------- ------- ------- ------- Revenues 48,596 93,939 48,569 Of which : License 45,847 91,190 45,847 Services 2,749 2,749 2,722 ------------ ------- ------- ------- The revenue recorded by NANOBIOTIX during the second quarter of 2014 relates to the upfront payment from the Taiwan-based PharmaEngine within the ... (more)

    Comment?

  15. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Jul 3, 2014 | Business Wire

    ... Issue Westpac Banking Corporation - Series 1098 USD 25,000,000 FRN due April 2016 ISIN Nu... )--Regulatory News: Nanobiotix (Paris:NANO): Place de cotation : Euronext Paris Compartiment : Compartiment C Code ISIN : FR0011341205 Site web : ...

    Comment?

  16. Nanotechnology: A rare metal that enhances radiotherapyRead the original story

    Jun 27, 2014 | Financial Times

    ... element, with just a few minor applications in the electronics and nuclear industries. Now a French company, Nanobiotix, is introducing hafnium to medicine for the first time, in the form of a product that enhances the impact of radiotherapy in ...

    Comment?

  17. Nanoparticle Drug Delivery Market Investigated by Kuick Research in...Read the original story

    Jun 18, 2014 | PRWeb

    ... maceuticals, Alnylam Pharmaceuticals, Arrowhead Research, BIND Biosciences, iCeutica, NanoCarrier, Nippon Kayaku, Nanobiotix and Samyang.

    Comment?

  18. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Jun 17, 2014 | Business Wire

    This report provides the key credit metrics for 46 Mexican corporates that ... )--The development of a tender option bond structure that complies with the Volcker rule paves the way for tax-exempt money market funds to remain a buyer of municipal... )--Regulatory News: NANOBIOTIX , sociA tA franA aise pionniA re en nanomA decine ... (more)

    Comment?

  19. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Jun 17, 2014 | Business Wire

    ... rule paves the way for tax-exempt money market funds to remain a buyer of municipal... )--Regulatory News: NANOBIOTIX (Paris:NANO)(Euronext : NANO - ISIN: FR0011341205), sociA tA franA aise pionniA re en nanomA decine ...

    Comment?

  20. ASCO Recap: Leaning in at the Plate, Swinging for the FencesRead the original story w/Photo

    Jun 17, 2014 | Bioscience Technology

    ... and the following is a summary of some of the more interesting players that made it on base: - Manufactured by Nanobiotix, of Paris, France, NBTXR3 is a nanoparticle formulation of hafnium oxide crystals. Hafnium is a heavy metal normally used in ...

    Comment?